Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Did I miss something

I agree, a reexam is not a courtcase...but in the Germany instance this was a court case to establish validity...just like the J's or the T's, or anyone else wanting to take us to court to establish the validity of the patents here in the US...I consider what occurred in Germany a court case not a reexam handled by the German Patent and Trademark Office...this was handled by a German Court...

And even if it was a reexam...that information has always been disclosed in the K's and Q's too in the ....RISK Factors section...

At the very least it should have been inserted here...



" Parties have petitioned the U. S. Patent and Trademark Office to re-examine certain of our

patents. An adverse decision in litigation or in the re-examination process could have a very

significant and adverse effect on our business."

.

JMHO

Share
New Message
Please login to post a reply